highperformr logo

Amgen's Overview

Total employees38814
HeadquartersThousand Oaks
Founded1980

Amgen is one ofthe world's leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Where is Amgen's Headquarters?

HQ Function

Serves as the central hub for global operations, corporate leadership, research and development (R&D) strategy, and administrative functions.

Notable Features:

A sprawling, modern campus featuring state-of-the-art research laboratories, advanced office buildings, and employee amenities such as fitness centers, cafes, and extensive green spaces. The campus design often emphasizes sustainability and collaboration.

Work Culture:

Characterized by a strong emphasis on scientific innovation, collaboration across disciplines, and a patient-centric mission. Employees often describe a dynamic and intellectually stimulating environment with opportunities for growth and development.

HQ Significance:

The Thousand Oaks headquarters is strategically important as the nerve center for Amgen's worldwide operations, guiding its research priorities, business development, and corporate strategy. It also represents Amgen's origins and sustained leadership in the biotechnology industry.

Values Reflected in HQ: The headquarters' design and function reflect Amgen's core values, including scientific excellence (advanced R&D facilities), innovation (collaborative workspaces), and a commitment to improving lives (focus on therapeutic development).

Location:

Amgen maintains a significant global presence, operating in approximately 100 countries across North America, South America, Europe, Asia, Australia, and the Middle East. This worldwide network supports a wide range of functions including research and development, manufacturing, clinical trials, commercial operations, sales and marketing, and distribution of its innovative medicines to patients globally.

Street Address:

One Amgen Center Drive

City:

Thousand Oaks

State/Province:

California

Country:

USA

Amgen's Global Presence

Cambridge, England, UK

Address: Granta Park, Great Abington, Cambridge, CB21 6GS, UK

Drives Amgen's R&D efforts in Europe, fostering collaborations with academic institutions and biotech companies in the region.

Breda, Netherlands

Address: Minervum 7061, 4817 ZK Breda, Netherlands

Critical for Amgen's supply chain and commercial operations across Europe, the Middle East, and Africa (EMEA).

Juncos, Puerto Rico, USA

Address: Road 31, Km 24.6, Juncos, PR 00777, USA

A vital part of Amgen's global manufacturing network, ensuring reliable supply of complex therapies and benefiting from Puerto Rico's established pharmaceutical manufacturing expertise.

Uxbridge, England, UK

Address: 216 Cambridge Science Park, Milton Road, Cambridge, CB4 0WA and Uxbridge Business Park, Sanderson Road, Uxbridge, UB8 1DH, UK

Manages the commercialization and availability of Amgen's products within the UK and Irish healthcare systems.

Buying Intent Signals for Amgen

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Amgen

As of April 2025, Amgen' leadership includes:

Robert A. Bradway - Chairman and Chief Executive Officer
Peter H. Griffith - Executive Vice President and Chief Financial Officer
David M. Reese, M.D. - Executive Vice President, Research and Development
Murdo Gordon - Executive Vice President, Global Commercial Operations
Arvind K. Sood - Executive Vice President, Operations
Jonathan P. Graham - Executive Vice President, General Counsel and Secretary
Lori Johnston - Senior Vice President, Human Resources

Investors of Amgen

Amgen has been backed by several prominent investors over the years, including:

The Vanguard Group, Inc.
BlackRock, Inc.
State Street Corporation
Capital Research Global Investors
Wellington Management Company LLP
Geode Capital Management, LLC

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits1

In the past year, Amgen announced a key leadership transition in its Research and Development division. Other top executive roles have remained stable.

Departures

David M. Reese, M.D., Announced intention to retire from his role as EVP, Research and Development by year-end 2024.

New Appointments:

Jay Bradner, M.D., Will join Amgen to succeed David M. Reese as EVP, Research and Development, and Chief Scientific Officer.

Technology (Tech Stack) used by Amgen

Discover the tools Amgen uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Amgen Email Formats and Examples

Amgen commonly uses the email format combining the first initial and last name of the employee. Variations may exist, but this is a widely observed pattern.

[first_initial][last]@amgen.com

Format

jdoe@amgen.com

Example

85%

Success rate

News and media

Amgen Press ReleaseMay 2, 2024

Amgen Reports First Quarter 2024 Financial Results

Amgen announced its financial results for the first quarter of 2024, reporting total revenues of $7.4 billion, a 22% increase compared to the first quarter of 2023, primarily driven by the Horizon Therapeutics acquisition and growth in key products....more

Amgen Press ReleaseMay 19, 2024

TEZSPIRE® Significantly Reduced Asthma Exacerbations In Patients With Severe Asthma Regardless Of Type 2 Inflammatory Status

New data presented at the ATS 2024 International Conference showed Tezspire (tezepelumab) consistently reduced asthma exacerbations requiring emergency room visits or hospitalization across a broad population of severe asthma patients....more

Amgen Press ReleaseMarch 5, 2024

Amgen Announces Planned Retirement of David M. Reese, M.D., EVP, Research and Development; Jay Bradner, M.D., to Succeed Reese

Amgen announced that David M. Reese, M.D., executive vice president, Research and Development, intends to retire at the end of 2024. Jay Bradner, M.D., will join Amgen as chief scientific officer and executive vice president, Research and Development, effective early 2025....more

Amgen Press ReleaseJanuary 29, 2024

Amgen Announces U.S. FDA Approval Of BEKEMV™ (eculizumab-aeeb), Biosimilar To Soliris® (eculizumab)

Amgen announced that the U.S. Food and Drug Administration (FDA) has approved BEKEMV™ (eculizumab-aeeb), a biosimilar to Soliris® (eculizumab), for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS)....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Amgen, are just a search away.